ArticleOPEN ACCESS

Minimal residual disease testing in multiple myeloma by flow cytometry: major heterogeneity.

Blood
DOI: 10.1182/blood-2013-05-506170
88Citations
Citations of this article
49Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Flanders, A., Stetler-Stevenson, M., & Landgren, O. (2013, August 8). Minimal residual disease testing in multiple myeloma by flow cytometry: major heterogeneity. Blood. https://doi.org/10.1182/blood-2013-05-506170

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free